855 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
2 Recruiting Feasibility of the Research for Mutation of K-ras and EGFR in CTCs From Metastatic Non Small Cells Bronchial Carcinomas
Condition: Non-small Cell Lung Cancer Metastatic
Intervention: Biological: CTC
3 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
4 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
5 Recruiting Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC
Condition: Stage III Non-small-Cell Lung Cancer
Intervention: Drug: Recombinant human endostatin
6 Recruiting Neoadjuvant Concurrent Chemoradiation With Weekly Docetaxel/Cisplatin for Resectable IIIA-N2 NSCLC
Condition: Non-small Cell Lung Cancer
Interventions: Drug: docetaxel/cisplatin;   Radiation: Radiation
7 Recruiting Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients
Conditions: Non Small-cell Lung Cancer;   Renal-cell Cancer;   Gastrointestinal Stroma Tumor
Interventions: Drug: Sunitinib;   Drug: Erlotinib;   Drug: Midazolam;   Drug: Caffeine
8 Not yet recruiting Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer
Conditions: Recurrent Non-small Cell Lung Cancer;   Stage IIA Non-small Cell Lung Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer
Interventions: Device: diffusion-weighted magnetic resonance imaging;   Device: 4-dimensional computed tomography;   Radiation: fludeoxyglucose F 18;   Device: FDG-PET
9 Unknown  Study of 3D Radiotherapy With or Without Erlotinib (Tarceva®) in Patients With Localized Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Erlotinib (Tarceva®)
10 Recruiting Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
Conditions: Advanced Solid Tumors;   Colorectal Cancer;   Squamous Cell Head and Neck Cancer;   Non Small Cell Lung Cancer;   Triple Negative Breast Cancer
Interventions: Drug: MM-151;   Drug: MM-151 + irinotecan
11 Recruiting Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors
Conditions: Breast Cancer;   Ovarian Cancer;   Gynecological Cancer;   Head and Neck Carcinoma;   Non-small Cell Lung Cancer;   Small Cell Lung Cancer;   Non-squamous Cell Lung Cancer
Intervention: Drug: PM01183 + paclitaxel +/- bevacizumab
12 Not yet recruiting Buparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors
Conditions: Recurrent Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: buparlisib;   Drug: gemcitabine hydrochloride;   Drug: cisplatin;   Other: pharmacological study;   Other: laboratory biomarker analysis;   Other: questionnaire administration
13 Recruiting The Jules Bordet Institute Molecular Profiling Program Feasibility Trial
Conditions: Metastic Colorectal Cancer.;   Metastatic Melanoma.;   Metastatic Non-small Cell Lung Cancer.
Intervention: Procedure: Biopsy of a metastatic lesion.
14 Recruiting Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Radiation: Stereotactic Body Radiation Therapy (SBRT);   Drug: cisplatin or carboplatin-based
15 Recruiting Erlotinib With or Without Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer With EGFR Mutations
Condition: Stage IV Non-small Cell Lung Cancer
Interventions: Drug: erlotinib;   Biological: bevacizumab;   Other: laboratory biomarker analysis
16 Recruiting A Study Of Dacomitinib (PF-00299804) In Patients With Advanced Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Drug: Dacomitinib
17 Not yet recruiting Study to Determine the Effect of Food on the Blood Levels of AZD9291 Following Oral Dosing of a Tablet Formulation in Patients With Non-Small Cell Lung Cancer
Conditions: Advanced Non Small Cell Lung Cancer;   Advanced (Inoperable) Non Small Cell Lung Cancer
Interventions: Drug: AZD9291 tablets;   Procedure: Pharmacokinetic sampling - AZD9291;   Other: Dietary Fasted;   Other: Dietary High Fat;   Procedure: Pharmacokinetic sampling - AZ5140 and AZ7550
18 Recruiting A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Custirsen + Docetaxel;   Drug: Docetaxel
19 Unknown  Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Drug: paclitaxel poliglumex
20 Recruiting Small Cell Lung Cancer Trial With IpiliMUmab in LImited Disease
Conditions: Limited Stage Small Cell Lung Cancer;   Small Cell Lung Cancer
Intervention: Drug: Ipilimumab

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years